Back

Real-world impact of implementing a 0/2-hour point-of-care high-sensitivity troponin pathway: interrupted time series and winter-matched difference-in-differences analysis

31 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Point-of-care testing in patients with chest pain: improving diagnosis among patients admitted to emergency department Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Faheem Asem Ahmad

NHS Greater Glasgow and Clyde, Glasgow (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Point-of-care echocardiography for decision making in patients with acute chest pain – the EPIC-ACS-Study
Mr B. Jurgeleit (Essen, DE)
Abstract
Presentation thumbnail
Next-generation risk stratification: leveraging TabPFN to Predict MACE in chest pain patients after acute myocardial infarction rule-out in the emergency department
Miss T. Tsao (Basel, CH)
Abstract
Presentation thumbnail
Can composite risk scores improve upon single sample rule-out performance in suspected acute coronary syndrome? A preplanned analysis of the MACROS 2 randomised controlled trial
Professor A. Khand (Liverpool, GB)
Abstract
Presentation thumbnail
Utilization of Point-Of-Care Testing (POCT) or troponin in patients with acute chest pain
Doctor H. Li (Hong Kong, HK)
Abstract
Presentation thumbnail
Impact of point-of-care high-sensitivity troponin testing on index admission and 30-day costs: secondary analysis of a randomised controlled trial
Doctor V. Thulin (Bergen, NO)
Abstract

Access the full session

Session thumbnail
Point-of-care testing in patients with chest pain: improving diagnosis among patients admitted to emergency department

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Appropriateness of high-sensitivity troponin testing and adherence to chest pain pathways across emergency and acute care units at a UK teaching hospital
20 March 2026
thumbnail
Congress Presentation
Prospective study of point of care device use in NT-proBNP therapeutic monitoring: substudy of GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Trial
29 June 2021
thumbnail
Congress Session
Real-world impact of point-of-care high-sensitivity troponin on emergency department flow: early results from a major United Kingdom tertiary centre
30 August 2026
thumbnail
Congress Presentation
The additive value of pre- and post-reperfusion cardiac troponin T levels in risk stratification of patients with ST-segment elevation myocardial infarction
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources